This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
Journal of Hematology & Oncology Open Access 03 August 2023
-
Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
Scientific Reports Open Access 04 September 2017
-
Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine
Blood Cancer Journal Open Access 01 November 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.
Sole F, Luno E, Sanzo C, Espinet B, Sanz GF, Cervera J et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005; 90: 1168–1178.
List AF, Vardiman J, Issa JP, DeWitte TM . Myelodysplastic Syndromes. Hematology 2004; 2004: 297–317.
Mori N, Morosetti R, Mizoguchi H, Koeffler HP . Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br J Haematol 2003; 122: 226–230.
Maeck L, Haase D, Schoch C, Hiddemann W, Alves F . Genetic instability in myelodysplastic syndrome: detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations. Br J Haematol 2000; 109: 842–846.
Cervantes RB, Stringer JR, Shao C, Tischfield JA, Stambrook PJ . Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 2002; 99: 3586–3590.
Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005; 65: 375–378.
Slater HR, Bailey DK, Ren H, Cao M, Bell K, Nasioulas S et al. High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet 2005; 77: 709–726.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gondek, L., Tiu, R., Haddad, A. et al. Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS. Leukemia 21, 2058–2061 (2007). https://doi.org/10.1038/sj.leu.2404745
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404745
This article is cited by
-
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
Journal of Hematology & Oncology (2023)
-
Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
Scientific Reports (2017)
-
Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance
Modern Pathology (2016)
-
The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China
Annals of Hematology (2016)
-
Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine
Blood Cancer Journal (2013)